Literature DB >> 7217048

Variant forms of plasma apolipoprotein B. Hepatic and intestinal biosynthesis and heterogeneous metabolism in the rat.

A L Wu, H G Windmueller.   

Abstract

Recent studies of circulating lipoproteins in man and the rat have shown that apolipoprotein B in plasma exists in two immunologically distinct forms with apparent Mr, in the rat, of approximately 335,000 (apoB335K) and 240,000 (apoB240K). With isolated, perfused organs and single and double isotope labeling methods in vivo (1979) J. Biol. Chem. 254, 7316), we have now found that the rat liver produces both apoB variants in abundance while the small intestine produces apoB240K but only trace amounts of apoB335K. The hepatic apoB335K/apoB240Kleucine incorporation ratio ranged from 0.5-1.7 under different conditions, suggesting physiological regulation of the relative amounts produced. Disappearance of both newly synthesized hepatic apoB variants from plasma followed first order kinetics. The circulating half-life of hepatic apoB335K was 2.4 times that of hepatic apoB240K, indicating independent catabolism of the two variants and consistent with the hepatic production of multiple apoB-containing lipoproteins with different metabolic properties. The half-life of apoB240K from the intestine was even shorter than that of apoB240K from the liver.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7217048

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  Epitopes of apolipoprotein B-100 and B-48 in both liver and intestine. Expression and evidence for local synthesis in recessive abetalipoproteinemia.

Authors:  R P Dullaart; B Speelberg; H J Schuurman; R W Milne; L M Havekes; Y L Marcel; H J Geuze; M M Hulshof; D W Erkelens
Journal:  J Clin Invest       Date:  1986-11       Impact factor: 14.808

2.  Detection of unique antigenic determinants on human plasma low density lipoprotein and on delipidated apolipoprotein B.

Authors:  T S Watt; R M Watt
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

3.  Kinetic analysis of plasma VLDL-TG and VLDL-remnant-TG turnover in anesthetized rats.

Authors:  R Bickerstaffe; I Lyon; H Rostami; N Baker; J Elovson
Journal:  Lipids       Date:  1983-08       Impact factor: 1.880

4.  The Hsp110 molecular chaperone stabilizes apolipoprotein B from endoplasmic reticulum-associated degradation (ERAD).

Authors:  Stacy L Hrizo; Viktoria Gusarova; David M Habiel; Jennifer L Goeckeler; Edward A Fisher; Jeffrey L Brodsky
Journal:  J Biol Chem       Date:  2007-09-06       Impact factor: 5.157

5.  Degradation of lipoproteins by human monocyte-derived macrophages. Evidence for two distinct processes for the degradation of abnormal very-low-density lipoprotein from subjects with type III hyperlipidaemia.

Authors:  A K Soutar; B L Knight
Journal:  Biochem J       Date:  1984-02-15       Impact factor: 3.857

6.  Effect of fatty acids on lipid and apoprotein secretion and association in hepatocyte cultures.

Authors:  W Patsch; T Tamai; G Schonfeld
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

7.  Apolipoprotein B detected in the plasma of a patient with homozygous hypobetalipoproteinaemia: implications for aetiology.

Authors:  G M Berger; G Brown; H E Henderson; F Bonnici
Journal:  J Med Genet       Date:  1983-06       Impact factor: 6.318

8.  The apoprotein B-independent hepatic uptake of chylomicron remnants.

Authors:  J Borensztajn; G S Getz; R J Padley; T J Kotlar
Journal:  Biochem J       Date:  1982-05-15       Impact factor: 3.857

9.  Human apolipoprotein B: identification of cDNA clones and characterization of mRNA.

Authors:  M Mehrabian; V N Schumaker; G C Fareed; R West; D F Johnson; T Kirchgessner; H C Lin; X B Wang; Y H Ma; E Mendiaz
Journal:  Nucleic Acids Res       Date:  1985-10-11       Impact factor: 16.971

10.  Cloning and expression of apolipoprotein B, the major protein of low and very low density lipoproteins.

Authors:  A J Lusis; R West; M Mehrabian; M A Reuben; R C LeBoeuf; J S Kaptein; D F Johnson; V N Schumaker; M P Yuhasz; M C Schotz
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.